Estimating the burden of SARS-CoV-2 in France
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
COVID-19 pandemic in France: Coronavirus disease 2019 (COVID-19) exacted a heavy toll in France during March and April 2020. Quarantine measures were effective in reducing transmission by 84%, and some relaxation of social isolation was expected in May. Salje et al. fit transmission models for the epidemic in France to hospital admissions. The authors forecast that 2.9 million people will have been infected by 11 May, representing 4.4% of the population—a value inadequate for herd immunity. Daily critical care hospitalizations should reduce from several hundreds to tens of cases, but control will remain a delicate balancing act. Any relaxation of lockdown in France will have to be carefully controlled and monitored to avoid undermining more optimistic forecasts. Science , this issue p. 208
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have estimated cumulative infections in select countries at specific points in time.6, 7, 8, 9”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
The effect of human mobility and control measures on the COVID-19 epidemic in China
Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., Open COVID-19 Data Working Group, du Plessis, L., Faria, N. R., Li, R., et al. (2020) · Science · doi:10.1126/science.abb4218 · Cited by 2,950
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Tian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Self-citationLinton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,361
How generation intervals shape the relationship between growth rates and reproductive numbers
Wallinga, J., & Lipsitch, M. (2007) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2006.3754 · Cited by 1,213
Cited by
Items 101–200 of 1,001
Human mobility and COVID-19 transmission: a systematic review and future directions
Zhang, M., Wang, S., Hu, T., Fu, X., Wang, X., Hu, Y., Halloran, B., Li, Z., Cui, Y., Liu, H., et al. (2022) · Annals of GIS · doi:10.1080/19475683.2022.2041725 · Cited by 103
The effect of eviction moratoria on the transmission of SARS-CoV-2
Nande, A., Sheen, J. K., Walters, E. L., Klein, B., Chinazzi, M., Gheorghe, A. H., Adlam, B., Shinnick, J. E., Tejeda, M. F., Scarpino, S. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22521-5 · Cited by 112
Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemicsPreprint
Aguas, R. J., Gonçalves, G., Ferreira, M. U., & Gomes, M. G. M. (2020) · medRxiv · doi:10.1101/2020.07.23.20160762 · Cited by 106
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
Al-Thani, M. H., Farag, E., Bertollini, R., Al Romaihi, H. E., Abdeen, S., Abdelkarim, A., Daraan, F., Elhaj Ismail, A. I. H., Mostafa, N., Sahl, M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab221 · Cited by 85
Zheng, H., Li, H., Guo, L., Liang, Y., Li, J., Wang, X., Hu, Y., Wang, L., Liao, Y., Yang, F., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008949 · Cited by 95
Dhakal, S., Ruiz-Bedoya, C. A., Zhou, R., Creisher, P. S., Villano, J., Littlefield, K. E., Castillo, J. R., Marinho, P. M., Jedlicka, A., Ordoñez, A. A., et al. (2021) · mBio · doi:10.1128/mbio.00974-21 · Cited by 100
Tuaillon, É., Bolloré, K., Pisoni, A., Debiesse, S., Renault, C., Marie, S., Groc, S., Niels, C., Pansu, N., Dupuy, A., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.077 · Cited by 99
Decerf, B., Ferreira, F. H. G., Mahler, D. G., & Sterck, O. C. (2020) · World Development · doi:10.1016/j.worlddev.2021.105561 · Cited by 107
Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study
Galmiche, S., Charmet, T., Schaeffer, L., Paireau, J., Grant, R., Chény, O., Platen, C. V., Maurizot, A., Blanc, C., Dinis, A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100148 · Cited by 102
Self-citationShared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Fadista, J., Kraven, L. M., Karjalainen, J. M., Andrews, S. J., Geller, F., Initiative, T. C.-1. H. G., Baillie, J. K., Wain, L. V., Jenkins, G. R., & Feenstra, B. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103277 · Cited by 96
Mahévas, M., Moulis, G., Andrès, E., Rivière, É., Garzaro, M., Crickx, É., Guillotin, V., Malphettes, M., Galicier, L., Noël, N., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17024 · Cited by 97
Khan, A. A., AlRuthia, Y. S., Balkhi, B. S., Alghadeer, S. M., Temsah, M.-H. A., Althunayyan, S. M., & Alsofayan, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207458 · Cited by 94
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
Vu, S. L., Jones, G., Anna, F., Rose, T., Richard, J., Bernard-Stoecklin, S., Goyard, S., Demeret, C., Helynck, O., Escriou, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23233-6 · Cited by 96
Campos, M. R., Schramm, J. M. D. A., Emmerick, I. C. M., Muzy, J., de Avelar, F. G., & Pimentel, T. G. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00148920 · Cited by 264
Pierron, D., Pereda‐Loth, V., Mantel, M., Moranges, M., Bignon, E., Alva, O., Kabous, J., Heiske, M., Pacalon, J., David, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18963-y · Cited by 95
Cost–benefit analysis of age‐specific deconfinement strategies
Gollier, C. (2020) · Journal of Public Economic Theory · doi:10.1111/jpet.12486 · Cited by 86
Modeling the second wave of COVID-19 infections in France and Italy via a stochastic SEIR model
Faranda, D., & Alberti, T. (2020) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0015943 · Cited by 94
Cappy, P., Candotti, D., Sauvage, V., Lucas, Q., Boizeau, L., Gomez, J., Enouf, V., Chabli, L., Pillonel, J., Tiberghien, P., et al. (2020) · Blood · doi:10.1182/blood.2020008230 · Cited by 86
Optimizing COVID-19 surveillance in long-term care facilities: a modelling study
Smith, D. R., Duval, A., Pouwels, K. B., Guillemot, D., Fernandes, J., Huynh, B.-T., Temime, L., & Opatowski, L. (2020) · BMC Medicine · doi:10.1186/s12916-020-01866-6 · Cited by 92
Self-citationAckah, M., Ameyaw, L., Salifu, M. G., Asubonteng, D. P. A., Yeboah, C. O., Annor, E., Ankapong, E. A. K., & Boakye, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268711 · Cited by 103
Ayoub, H. H., Chemaitelly, H., Seedat, S., Makhoul, M., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05005 · Cited by 81
Chouchou, F., Augustini, M., Caderby, T., Caron, N., Turpin, N. A., & Dalleau, G. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.09.014 · Cited by 92
Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait
Alshukry, A., Ali, H., Ali, Y., Al-Taweel, T., Abu‐Farha, M., Abubaker, J. A., Devarajan, S., Dashti, A. A., Bandar, A., Taleb, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242768 · Cited by 84
COVID-19 in ocrelizumab-treated people with multiple sclerosis
Hughes, R. A., Whitley, L., Fitovski, K., Schneble, H., Rouzic, E. M., Sauter, A., Craveiro, L., Dillon, P., Bonati, U., Jessop, N., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102725 · Cited by 82
Ethical Implementation of Immunity Passports During the COVID-19 Pandemic
Voo, T. C., Clapham, H., & Tam, C. C. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa352 · Cited by 82
Anatomy of digital contact tracing: Role of age, transmission setting, adoption, and case detection
López, J. A. M., García, B. A., Bentkowski, P., Bioglio, L., Pinotti, F., Boëlle, P., Barrat, A., Colizza, V., & Poletto, C. (2021) · Science Advances · doi:10.1126/sciadv.abd8750 · Cited by 89
Bajos, N., Jusot, F., Pailhé, A., Spire, A., Martin, C., Meyer, L., Lydié, N., Franck, J.-E., Zins, M., Carrat, F., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10521-5 · Cited by 92
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
Aguas, R. J., Mahdi, A., Shretta, R., Horby, P., Landray, M., White, L. J., Arifi, F., Zhumalieva, C., Lubis, I. N. D., Monteiro, A. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21134-2 · Cited by 82
Gęca, T., Wojtowicz, K., Guzik, P. W., & Góra, T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116555 · Cited by 86
Attema, A. E., L’Haridon, O., Raude, J., Seror, V., & The COCONEL Group (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.619145 · Cited by 89
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
Gallay, L., Uzunhan, Y., Borie, R., Lazor, R., Rigaud, P., Marchand-Adam, S., Hirschi, S., Israël‐Biet, D., Valentin, V., & Cottin, V. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2638le · Cited by 75
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Bonam, S. R., Kotla, N. G., Bohara, R. A., Rochev, Y. A., Webster, T. J., & Bayry, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101051 · Cited by 79
Scherlinger, M., Felten, R., Gallais, F., Nazon, C., Chatelus, E., Pijnenburg, L., Mengin, A. C., Gras, A., Vidailhet, P., Arnould-Michel, R., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00484-w · Cited by 82
Herrera, D., & Campos, G. D. L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07262-0 · Cited by 81
Charpentier, A., Élie, R., Laurière, M., & Tran, V. C. (2020) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/2020045 · Cited by 1,017
Scully, E. P., Schumock, G., Fu, M., Massaccesi, G., Muschelli, J., Betz, J., Klein, E. Y., West, N. E., Robinson, M., Garibaldi, B. T., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab448 · Cited by 73
“Early reports from Wuhan, China [1, 2], and European countries [3] showed higher rates of hospitalization, intensive care unit (ICU) admission, and mortality in males.”
BackgroundResultPoline, J., Gaschignard, J., Leblanc, C., Madhi, F., Foucaud, E., Nattes, E., Faye, A., Bonacorsi, S., Mariani‐Kurkdjian, P., Varon, E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1044 · Cited by 89
Bauer, S., Contreras, S., Dehning, J., Linden, M., Iftekhar, E. N., Mohr, S., Olivera‐Nappa, Á., & Priesemann, V. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009288 · Cited by 81
Platelet activation in critically ill COVID-19 patients
Yatim, N., Boussier, J., Chocron, R., Hadjadj, J., Philippe, A., Gendron, N., Barnabei, L., Charbit, B., Szwebel, T., Carlier, N., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00899-1 · Cited by 77
Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic
Richard, Q., Alizon, S., Choisy, M., Sofonea, M. T., & Djidjou‐Demasse, R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008776 · Cited by 67
Sermet‐Gaudelus, I., Temmam, S., Huon, C., Behillil, S., Gajdos, V., Bigot, T., Lurier, T., Chrétien, D., Backović, M., Delaunay, A., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.13.2001782 · Cited by 72
Data-driven methods for present and future pandemics: Monitoring, modelling and managing
Álamo, T., Reina, D. G., Millán, P., Preciado, V. M., & Giordano, G. (2021) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2021.05.003 · Cited by 78
COVID-19: One-month impact of the French lockdown on the epidemic burdenPreprint
Roux, J., Massonnaud, C., & Crépey, P. (2020) · medRxiv · doi:10.1101/2020.04.22.20075705 · Cited by 69
The role of schools and school-aged children in SARS-CoV-2 transmission
Flasche, S., & Edmunds, W. J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30927-0 · Cited by 64
A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection
Singh, M., Chazal, M., Quarato, P., Bourdon, L., Malabat, C., Vallet, T., Vignuzzi, M., van der Werf, S., Behillil, S., Donati, F., et al. (2021) · EMBO Reports · doi:10.15252/embr.202154341 · Cited by 65
Huang, X., Zhang, X., Machireddy, N., Evans, C. E., Trewartha, S., Hu, G., Fang, Y. H., Mutlu, G. M., Wu, D., & Zhao, Y. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abm5755 · Cited by 77
Modelling the COVID-19 pandemic in context: an international participatory approach
Aguas, R. J., White, L. J., Hupert, N., Shretta, R., Ngum, W. P., Celhay, O., Moldokmatova, A., Arifi, F., Mirzazadeh, A., Sharifi, H. P., et al. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003126 · Cited by 72
Levin, A., Hanage, W. P., Owusu‐Boaitey, N., Cochran, K., Walsh, S. P., & Meyerowitz‐Katz, G. (2020) · National Bureau of Economic Research · doi:10.3386/w27597 · Cited by 71
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
Seedat, S., Chemaitelly, H., Ayoub, H. H., Makhoul, M., Mumtaz, G. R., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97606-8 · Cited by 63
COVID-19: A Boon or a Bane for Creativity?
Mercier, M., Vinchon, F., Pichot, N., Bonetto, É., Bonnardel, N., Girandola, F., & Lubart, T. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.601150 · Cited by 80
An ensemble model based on early predictors to forecast COVID-19 health care demand in France
Paireau, J., Andronico, A., Hozé, N., Layan, M., Crépey, P., Roumagnac, A., Lavielle, M., Boëlle, P., & Cauchemez, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103302119 · Cited by 66
Self-citationWarszawski, J., Beaumont, A., Seng, R., de Lamballerie, X. N., Rahib, D., Lydié, N., Slama, R., Durrleman, S., Raynaud, P., Sillard, P., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-021-06973-0 · Cited by 76
Hozé, N., Paireau, J., Lapidus, N., Kiem, C. T., Salje, H., Severi, G., Touvier, M., Zins, M., de Lamballerie, X. N., Lévy-Bruhl, D., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00064-5 · Cited by 64
Self-citationPelleau, S., Woudenberg, T., Rosado, J., Donnadieu, F., García, L., Obadia, T., Gardais, S., Elgharbawy, Y., Velay, A., Gonzalez, M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab375 · Cited by 65
Self-citationMerdji, H., Curtiaud, A., Aheto, A., Studer, A., Harjola, V., Monnier, A., Duarte, K., Girerd, N., Kibler, M., Ait‐Oufella, H., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202204-0687oc · Cited by 67
Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes
Zeng, H.-L., Dichio, V., Rodríguez-Horta, E., Thorell, K., & Aurell, E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012331117 · Cited by 80
Modelling insights into the COVID-19 pandemic
Meehan, M. T., Rojas, D. P., Adekunle, A. I., Adegboye, O. A., Caldwell, J. M., Turek, E. M., Williams, B. M., Marais, B. J., Trauer, J. M., & McBryde, E. S. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.06.014 · Cited by 67
Lockdown impact on COVID-19 epidemics in regions across metropolitan France
Cauchemez, S., Kiem, C. T., Paireau, J., Rolland, P., & Fontanet, A. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32034-1 · Cited by 60
Self-citationEffects of social distancing on the spreading of COVID-19 inferred from mobile phone data
Khataee, H., Scheuring, I., Czirók, A., & Neufeld, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-81308-2 · Cited by 64
Fava, E. D., Cimentada, J., Perrotta, D., Grow, A., Rampazzo, F., Gil‐Clavel, S., & Zagheni, E. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050651 · Cited by 70
Real-time pandemic surveillance using hospital admissions and mobility data
Fox, S. J., Lachmann, M., Tec, M., Pasco, R. F., Woody, S., Du, Z., Wang, X., Ingle, T. A., Javan, E. M., Dahan, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111870119 · Cited by 66
Czuppon, P., Débarre, F., Gonçalves, A., Tenaillon, O., Perelson, A. S., Guedj, J., & Blanquart, F. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008752 · Cited by 64
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
Basse, C., Diakite, S., Servois, V., Frélaut, M., Noret, A., Bellesœur, A., Moreau, P., Massiani, M.-A., Bouyer, A.-S., Vuagnat, P., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa090 · Cited by 64
Lachassinne, E., de Pontual, L., Caséris, M., Lorrot, M., Guilluy, C., Naud, A., Dommergues, M., Pinquier, D., Wannepain, E., Hausherr, E., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00024-9 · Cited by 66
Smoking and risk of COVID-19 hospitalization
Neira, D. A. P., Watts, A., Seashore, J., Polychronopoulou, E., Kuo, Y., & Sharma, G. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106414 · Cited by 72
Mohammadi, M., Dehghan, M., Pirayesh, A., & Dolgui, A. B. (2022) · Omega · doi:10.1016/j.omega.2022.102725 · Cited by 59
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Patel, J., Bass, D., Beishuizen, A., Bocca Ruiz, X., Boughanmi, H., Cahn, A., Colombo, H., Criner, G. J., Davy, K., de-Miguel-Díez, J., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.01870-2021 · Cited by 59
Why lockdown of the elderly is not ageist and why levelling down equality is wrong
Savulescu, J., & Cameron, J. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106336 · Cited by 57
High‐Resolution Agent‐Based Modeling of COVID‐19 Spreading in a Small Town
Truszkowska, A., Behring, B., Hasanyan, J., Zino, L., Butail, S., Caroppo, E., Jiang, Z., Rizzo, A., & Porfiri, M. (2021) · Advanced Theory and Simulations · doi:10.1002/adts.202000277 · Cited by 74
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort
Lano, G., Braconnier, A., Bataille, S., Cavaillé, G., Moussi‐Francès, J., Gondouin, B., Bindi, P., Nakhla, M., Mansour, J., Halin, P., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa199 · Cited by 61
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
Schaefer, G. O., Tam, C. C., Savulescu, J., & Voo, T. C. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.007 · Cited by 55
Cheng, Y., Cao, X., Cao, Z., Xu, C., Sun, L. N., Gao, Y., Wang, Y., Li, S., Wu, C., Li, X., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101124 · Cited by 61
Shapiro, J. R., Sitaras, I., Park, H. S., Aytenfisu, T. Y., Caputo, C. A., Li, M., Lee, J., Johnston, T. S., Li, H., Wouters, C., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac397 · Cited by 58
Yang, W., Shaff, J., & Shaman, J. L. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0822 · Cited by 59
Convolutional neural networks and temporal CNNs for COVID-19 forecasting in France
Mohimont, L., Chemchem, A., Alin, F., Krajecki, M., & Steffenel, L. A. (2021) · Applied Intelligence · doi:10.1007/s10489-021-02359-6 · Cited by 56
Pathela, P., Crawley, A., Weiss, D., Maldin, B., Cornell, J., Purdin, J., Schumacher, P. K., Marovich, S., Li, J., Daskalakis, D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab200 · Cited by 52
Observational study of haloperidol in hospitalized patients with COVID-19
Hoertel, N., Rico, M. S., Vernet, R., Jannot, A., Neuraz, A., Blanco, C., Lemogne, C., Airagnes, G., Paris, N., Daniel, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247122 · Cited by 60
Kiem, C. T., Massonnaud, C., Lévy-Bruhl, D., Poletto, C., Colizza, V., Bosetti, P., Fontanet, A. L., Gabet, A., Olié, V., Zanetti, L. C. D. S., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101001 · Cited by 61
Self-citationHeterogeneous social interactions and the COVID-19 lockdown outcome in a multi-group SEIR model
Jean Dolbeault, A., & Turinici, G. (2020) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/2020025 · Cited by 58
Costantino, F., Bahier, L., Coronel, L., Leboime, A., Vidal, F., Bessalah, L., Bréban, M., & D’Agostino, M. A. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.105095 · Cited by 55
Ayoub, H. H., Mumtaz, G. R., Seedat, S., Makhoul, M., Chemaitelly, H. S., & Abu-Raddad, L. J. (2021) · Global Epidemiology · doi:10.1016/j.gloepi.2021.100068 · Cited by 53
Association of HLA‐ DRB1 *09:01 with severe COVID ‐19
Anzurez, A., Naka, I., Miki, S., Nakayama‐Hosoya, K., Isshiki, M., Watanabe, Y., Nakamura‐Hoshi, M., Seki, S., Matsumura, T., Takano, T., et al. (2021) · HLA · doi:10.1111/tan.14256 · Cited by 60
The optimal allocation of Covid-19 vaccines
Babus, A., Das, S., & Lee, S. M. (2023) · Economics Letters · doi:10.1016/j.econlet.2023.111008 · Cited by 50
Memory is key in capturing COVID-19 epidemiological dynamics
Sofonea, M. T., Reyné, B., Elie, B., Djidjou‐Demasse, R., Selinger, C., Michalakis, Y., & Alizon, S. (2021) · Epidemics · doi:10.1016/j.epidem.2021.100459 · Cited by 83
Walger, P., Heininger, U., Knuf, M., Exner, M., Popp, W., Fischbach, T. J., Trapp, S., Hübner, J., Herr, C. E. W., Simon, A., et al. (2020) · PubMed Central · doi:10.3205/dgkh000346 · Cited by 54
Brazeau, N. F., Verity, R., Jenks, S. J., Fu, H., Whittaker, C., Winskill, P., Dorigatti, I., Walker, P. G. T., Riley, S., Schnekenberg, R. P., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00106-7 · Cited by 60
Sofonea, M. T., Roquebert, B., Foulongne, V., Morquin, D., Verdurme, L., Trombert‐Paolantoni, S., Roussel, M., Bonetti, J.-C., Zerah, J., Haïm‐Boukobza, S., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2807.220033 · Cited by 56
Estimating COVID-19 under-reporting across 86 nations: implications for projections and controlPreprint
Rahmandad, H., Lim, T. Y., & Sterman, J. D. (2020) · medRxiv · doi:10.1101/2020.06.24.20139451 · Cited by 57
Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
Söderberg‐Nauclér, C. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00218-z · Cited by 55
Systematic review of predictive mathematical models of COVID-19 epidemic
Shankar, S., Mohakuda, S. S., Kumar, A., Nazneen, P. S., Yadav, A. K., Chatterjee, K. D., & Chatterjee, K. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.05.005 · Cited by 49
Nanoelectrokinetic-Assisted Lateral Flow Assay for COVID-19 Antibody Test
Kim, C., Yoo, Y. K., Lee, N. E., Lee, J., Kim, K. H., Lee, S.-M., Kim, J., Park, S. J., Lee, D., Lee, S. W., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114385 · Cited by 50
Waning Immunity and the Second Wave: Some Projections for SARS-CoV-2
Giannitsarou, C., Kissler, S. M., & Toxvaerd, F. (2021) · American Economic Review Insights · doi:10.1257/aeri.20200343 · Cited by 56
Arthur, L., Esaulova, E., Mogilenko, D. A., Tsurinov, P., Burdess, S., Laha, A., Presti, R. M., Goetz, B. D., Watson, M. A., Goss, C. W., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00067-x · Cited by 51
Sethi, S., Kumar, A., Mandal, A., Shaikh, M. A. K., Hall, C. A., Kirk, J. M. W., Moss, P. A. H., Brookes, M., & Basu, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-048856 · Cited by 57
Keller, N., Chantrel, F., Krummel, T., Bazin-Kara, D., Faller, A. L., Muller, C., Nussbaumer, T., Ismer, M., Benmoussa, A., Brahim-Bouna, M., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa170 · Cited by 53
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana
Andronico, A., Kiem, C. T., Paireau, J., Succo, T., Bosetti, P., Lefrancq, N., Nacher, M., Djossou, F., Sanna, A., Flamand, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21944-4 · Cited by 57
Self-citationXimenes, R. A. D. A., de Albuquerque, M. D. F. P. M., Martelli, C. M. T., de Araújo, T. V. B., Miranda-Filho, D. D. B., de Souza, W. V., Ichihara, M. Y., de Lira, P. I. C., Kerr, L. R. F. S., Aquino, E. M. L., et al. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021264.39422020 · Cited by 56
Let's Talk About Sex—Biological Sex Is Underreported in Biomaterial Studies
James, B. D., Guerin, P., & Allen, J. B. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001034 · Cited by 48
Exposome-based public health interventions for infectious diseases in urban settings
Andrianou, X. D., Pronk, A., Galea, K. S., Stierum, R. H., Loh, M. M., Riccardo, F., Pezzotti, P., & Makris, K. C. (2020) · Environment International · doi:10.1016/j.envint.2020.106246 · Cited by 51
The impact of the COVID-19 lockdown on global air quality: A review
Saha, L., Kumar, A., Kumar, S., Korstad, J., Srivastava, S., & Bauddh, K. (2022) · Environmental Sustainability · doi:10.1007/s42398-021-00213-6 · Cited by 61
Metadata
- Authors
- Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., & Cauchemez, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
- Ministère des Solidarités et de la Santé (FR)
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
- Johns Hopkins University (US)
- Conservatoire National des Arts et Métiers (FR)
- Inserm (FR)
- Institut Pierre Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
- Corresponding author
- Cauchemez, Simon
- ORCID
- Venue
- Science
- Published
- 2020-07-10
- Volume
- 369
- Issue
- 6500
- Pages
- 208-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7223792
- OpenAlex
- W3025090814
- Cited by
- 1,038
- References
- 30
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 50 · 2023: 90 · 2022: 171 · 2021: 378 · 2020: 303
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion, cc-by-nc)
- Funders
- H2020 European Research Council (804744)
- ANR (ANR-10-LABX-62-IBEID)
- INCEPTION (PIA/ANR-16-CONV-0005)
- Santé Publique France
- European Union RECOVER
- University of Cambridge COVID-19 Rapid Response Grant
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, hospitalization rates, mortality rates, lockdown, reproduction number, herd immunity, age and sex differences, intensive care, second wave, France
- MeSH terms
- COVID-19, Adolescent, Adult, Aged, Aged, 80 and over, Critical Care, Female, France, Hospitalization, Humans, Immunity, Male, Middle Aged, Pneumonia, Viral, Quarantine, Cost of Illness, Coronavirus Infections, Severe acute respiratory syndrome-related coronavirus, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.